Endocrine Response in Women With Invasive Lobular Breast Cancer

NCT02206984 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

201

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tamoxifen
DRUG: Anastrozole
DRUG: Fulvestrant

Sponsor

Priscilla McAuliffe